V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003511 | 330001803 | 1.8 | 41.8 | Neo-adjuvant (N) | 2015-08-22 | 2015-09-17 | Cetuximab 7 day (Cycle 1) | N | Y | 330013034 | CETUXIMAB |
| 330003512 | 330001803 | null | 51.8 | Neo-adjuvant (N) | 2014-08-13 | 2014-08-14 | Dox + HD Mtx (post PAM) | null | null | 330013034 | DOXORUBICIN + HD MTX |
| 330003513 | 330001804 | 1.5 | 24 | Disease modification (D) | 2015-04-30 | 2015-05-10 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330013040 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003514 | 330001804 | 1.69 | 84.1 | Neo-adjuvant (N) | 2013-09-26 | 2013-09-26 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 330013040 | EURO-EWING |
| 330003515 | 330001805 | 1.79 | 109.8 | Curative (C) | 2017-09-13 | 2017-09-13 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330013044 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003516 | 330001805 | 0 | 61.1 | Neo-adjuvant (N) | 2013-10-18 | 2013-10-18 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330013044 | CARBO + FLUOROURACIL |
| 330003517 | 330009763 | 1.73 | 54.7 | Neo-adjuvant (N) | null | 2015-09-28 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 330013054 | CISPLATIN + GEMCITABINE |
| 330003518 | 330009763 | 1.64 | 78.9 | Neo-adjuvant (N) | 2017-01-06 | 2017-01-12 | EW EuroEwing 2012 Arm A VIDE | N | N | 330013054 | EURO-EWING |
| 330003519 | 330009763 | 1.65 | 37.9 | Palliative (P) | 2013-07-26 | 2013-08-07 | CARBOPLATIN + FLUOROURACIL | N | N | 330013054 | CARBO + FLUOROURACIL |
| 330003520 | 330009763 | 1.68 | 29 | Curative (C) | 2018-02-21 | 2018-02-21 | CARBO + FLUOROURACIL | null | N | 330013054 | CARBO + FLUOROURACIL |
| 330003521 | 330009763 | 1.57 | null | null | 2016-08-11 | 2016-08-11 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013054 | CARBO + FLUOROURACIL |
| 330003522 | 330009763 | 1.66 | 100 | Curative (C) | 2016-02-09 | 2016-02-21 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330013054 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003523 | 330009763 | 1.71 | 39.8 | null | 2016-09-21 | 2016-09-21 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330013054 | MAP |
| 330003524 | 330013274 | 1.66 | 69.1 | Curative (C) | 2013-12-31 | 2014-01-11 | OST Euramos 1 Closed Trial - AP | N | N | 330013067 | MAP |
| 330003525 | 330001806 | null | null | Palliative (P) | 2016-06-07 | 2016-06-12 | CAP | N | N | 330013071 | CAP |
| 330003526 | 330001807 | 1.66 | 162.9 | Palliative (P) | 2016-11-18 | 2016-11-23 | CAP | N | N | 330013074 | CAP |
| 330003527 | 330001808 | 1.69 | 73.8 | Not known (9) | 2017-09-15 | 2017-09-18 | Cetuximab + Radiotherapy Maint | Y | N | 330013076 | CETUXIMAB + RT |
| 330003528 | 330001809 | 1.5 | 100 | Disease modification (D) | 2015-01-27 | 2015-01-28 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330013078 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003529 | 330006974 | 1.88 | 79.2 | Palliative (P) | 2014-12-27 | 2015-01-09 | GemCarbo Days 1+8 | N | N | 330013080 | GEMCARBO |
| 330003530 | 330001810 | 1.57 | 34 | Palliative (P) | 2017-05-24 | 2017-05-30 | CARBO + FLUOROURACIL | N | N | 330013082 | CARBO + FLUOROURACIL |
| 330003531 | 330006975 | 1.63 | 57 | Palliative (P) | 2015-02-14 | 2015-02-23 | Cisplatin + Etoposide (5 day) | N | N | 330013085 | CISPLATIN + ETOPOSIDE |
| 330003532 | 330001811 | 1.6 | 72.4 | Curative (C) | 2016-03-29 | 2016-04-26 | EW EuroEwing 2012 Arm A VIDE | N | N | 330013092 | EURO-EWING |
| 330003533 | 330001812 | 1.39 | null | null | 2018-06-20 | 2018-06-27 | CARBO + FLUOROURACIL | N | N | 330013094 | CARBO + FLUOROURACIL |
| 330003534 | 330001813 | 1.59 | 75 | Curative (C) | 2013-02-19 | 2013-02-20 | Dox + HD Mtx (post PAM) | 02 | null | 330013095 | DOXORUBICIN + HD MTX |
| 330003535 | 330001813 | 1.7 | 96.5 | Curative (C) | 2017-01-24 | 2017-02-07 | CAP | N | N | 330013095 | CAP |
| 330003536 | 330001813 | 1.66 | 121 | null | 2017-07-16 | 2017-07-16 | CAP | 02 | N | 330013095 | CAP |
| 330003537 | 330011316 | 1.69 | 56.4 | Not known (9) | 2018-03-04 | 2018-03-07 | Cetuximab + Radiotherapy Load | 02 | null | 330013098 | CETUXIMAB + RT |
| 330003538 | 330011316 | 1.71 | 72.2 | Not known (9) | 2014-01-24 | 2014-01-27 | CARBO + FLUOROURACIL | 02 | N | 330013098 | CARBO + FLUOROURACIL |
| 330003539 | 330001814 | 1.5 | 42.5 | Neo-adjuvant (N) | 2014-03-11 | 2014-04-10 | Dox + HD Mtx (post PAM) | N | N | 330013104 | DOXORUBICIN + HD MTX |
| 330003540 | 330001814 | 0 | null | null | null | 2016-02-24 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 330013104 | CARBO + FLUOROURACIL |
| 330003541 | 330001814 | 1.77 | 62.1 | Curative (C) | 2017-04-16 | 2017-04-16 | Cetuximab + Radiotherapy Load | N | Y | 330013104 | CETUXIMAB + RT |
| 330003542 | 330001814 | 1.83 | 74.5 | null | 2016-10-27 | 2016-10-30 | DA 3 + 10 | 02 | N | 330013104 | DA |
| 330003543 | 330001814 | 1.72 | 50.7 | null | 2015-05-10 | 2015-05-31 | GemCarbo Days 1+8 | N | N | 330013104 | GEMCARBO |
| 330003544 | 330001814 | 1.61 | 88.3 | Curative (C) | 2014-08-10 | 2014-08-12 | EURAMOS TRIAL | N | N | 330013104 | EURAMOS TRIAL |
| 330003545 | 330012946 | 1.47 | 79.5 | Palliative (P) | 2013-09-24 | 2013-09-24 | CISPLATIN + GEMCITABINE | 02 | N | 330013113 | CISPLATIN + GEMCITABINE |
| 330003546 | 330001815 | 1.64 | 88.3 | Curative (C) | 2013-06-25 | 2013-06-27 | DA | N | N | 330013115 | DA |
| 330003547 | 330001816 | 1.84 | 78 | Neo-adjuvant (N) | 2016-09-26 | 2016-10-05 | CVP R | N | N | 330013122 | CVP R |
| 330003548 | 330001817 | 1.59 | 32 | Neo-adjuvant (N) | 2016-04-17 | 2016-04-22 | Dox + HD Mtx (post PAM) | Y | N | 330013123 | DOXORUBICIN + HD MTX |
| 330003549 | 330001818 | 1.71 | 96.4 | Curative (C) | 2015-01-11 | 2015-01-19 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 330013125 | EURO-EWING |
| 330003550 | 330001819 | 1.63 | 70.8 | Disease modification (D) | 2014-01-13 | 2014-01-22 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330013135 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003551 | 330001819 | 1.6 | 62.5 | Curative (C) | 2013-01-29 | 2013-02-01 | DA | N | N | 330013135 | DA |
| 330003552 | 330001820 | 1.75 | 81.1 | Neo-adjuvant (N) | null | 2014-12-30 | Dox + HD Mtx (post PAM) | null | null | 330013139 | DOXORUBICIN + HD MTX |
| 330003553 | 330001821 | null | 61.6 | Curative (C) | 2015-01-13 | 2015-01-15 | DA 3 + 10 | N | N | 330013142 | DA |
| 330003554 | 330001822 | 1.1 | 64.5 | Curative (C) | 2015-10-27 | 2015-11-06 | OST Euramos 1 Closed Trial - AP | N | N | 330013145 | MAP |
| 330003555 | 330001822 | 1.79 | 82.1 | Palliative (P) | 2016-10-31 | 2016-10-31 | GemCarbo Days 1+8 | N | N | 330013145 | GEMCARBO |
| 330003556 | 330001823 | null | 85 | Palliative (P) | 2015-06-23 | 2015-06-28 | EW EuroEwing 2012 Arm A VIDE | null | N | 330013152 | EURO-EWING |
| 330003557 | 330001823 | 1.62 | 28.6 | Neo-adjuvant (N) | 2017-07-24 | 2017-08-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330013152 | CISPLATIN + GEMCITABINE |
| 330003558 | 330001824 | 1.54 | 65.6 | Curative (C) | 2017-02-21 | 2017-03-09 | DA 3+8 | 02 | null | 330013154 | DA |
| 330003559 | 330001824 | null | 59.1 | Disease modification (D) | 2017-04-12 | 2017-04-13 | Cyclophosphamide + Dex + Rituximab | null | Y | 330013154 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003560 | 330001824 | null | 57.2 | Neo-adjuvant (N) | 2014-03-30 | 2014-03-31 | CARBOPLATIN + FLUOROURACIL | N | N | 330013154 | CARBO + FLUOROURACIL |